Clinical Trials Logo

Brain Injuries clinical trials

View clinical trials related to Brain Injuries.

Filter by:

NCT ID: NCT02544542 Completed - Clinical trials for Hypoxic-Ischemic Encephalopathy

Clinical Trial of a New Rectum Cooling System on Patients of Hypoxic-ischemic Brain Damage

Start date: January 2014
Phase: N/A
Study type: Interventional

This study will try to evaluate the effectiveness and safety of a new method for achieving mild hypothermia, i.e.,mild hypothermia therapy through rectum. Half of participants will be treated by the widely-used hyper-hypothermia blanket method, while the other half will be treated by the investigators' new method.

NCT ID: NCT02541123 Completed - Clinical trials for Traumatic Brain Injury

Evaluation of Biomarker Kinetics After Mild Brain Injury Trauma

VIGILANT
Start date: January 2016
Phase:
Study type: Observational

The primary objective of the clinical trial is to evaluate the effect of time on levels of Ubiquitin C-terminal Hydrolase-L1 (UCH-L1) and Glial Fibrillary Acidic Protein (GFAP) biomarker levels in a population of head injured subjects over the age of 18 presenting acutely with a Glasgow Coma Scale score 13-15 as well as in a group of uninjured control subjects.

NCT ID: NCT02536079 Recruiting - Brain Injury Clinical Trials

NeuroAiD Safe Treatment Registry

NeST
Start date: June 2014
Phase:
Study type: Observational [Patient Registry]

The NeST registry is a pro-active industry-academic collaboration to assess the use and safety of NeuroAiD in the real world setting. An online entry system was set up to allow easy data entry and retrieval of clinical information.

NCT ID: NCT02525432 Active, not recruiting - Clinical trials for Brain Injuries, Traumatic

Autologous Stem Cell Study for Adult TBI (Phase 2b)

Start date: November 21, 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the effect of intravenous infusion of autologous bone marrow mononuclear cells (BMMNC) on brain structure and neurocognitive/functional outcomes after severe traumatic brain (TBI) injury in adults. The primary objective is to determine if the intravenous infusion of autologous BMMNC after severe TBI results in structural preservation of global gray matter (GM) volume and white matter (WM) volume and integrity; as well as select regions of interest in the corpus callosum. THe secondary objectives are to determine if autologous BMMNC infusion improves functional and neurocognitive deficits in adults after TBI; reduces the neuroinflammatory response to TBI; evaluate spleen size and splenic blood flow over time using ultrasound and corresponding changes in inflammatory cytokines; and infusion related toxicity and long-term follow-up safety evaluations.

NCT ID: NCT02524067 Completed - Clinical trials for Traumatic Brain Injury (TBI)

Modified Environment for Agitation in Patients With TBI

ABS
Start date: September 2015
Phase: N/A
Study type: Interventional

This study examines the effect of an intervention consisting of dynamic circadian light and sound therapy, as well as systematic information on sleep pattern, agitated behavior and functioning level.

NCT ID: NCT02522429 Terminated - Brain Injuries Clinical Trials

Thalamic Low Intensity Focused Ultrasound in Brain Injury

LIFUP
Start date: March 10, 2016
Phase: N/A
Study type: Interventional

Few neurological conditions are as scientifically mysterious and clinically, legally, and ethically challenging as disorders of consciousness. To date there exists no standard intervention for patients suffering from these devastating conditions. The present project is aimed at evaluating the potential of non-invasive Low Intensity Focused Ultrasound Pulsation (LIFUP) of thalamus (a key area for the consciousness network) as a neurorestorative stimulation for those patients. In this study, LIFUP will be performed during two sessions. The proposed experiment will involve behavioral and paramedical measurements just before and after each of the two LIFUP sessions in a small sample of patients (up to 15 acute and 15 chronic patients) in order to evaluate the feasibility of a full scale clinical trial.

NCT ID: NCT02517073 Completed - Clinical trials for Respiration, Artificial

Practice of Mechanical Ventilation in Patients With Severe Brain Injury in China

Start date: August 2015
Phase: N/A
Study type: Observational

The mechanical ventilation strategy has changed over years worldwide. Several international researches have been conducted to study the association of the use of mechanical ventilation with clinical outcomes. In this prospective, multicenter, cross-sectional survey, the practice of mechanical ventilation among patients with severe brain injury will be investigated in 70 intensive care units in China.

NCT ID: NCT02514902 Completed - Clinical trials for Traumatic Brain Injury

Stroke and Traumatic Acute Brain Injury Line Indicator System for Emergent Recognition (STABILISER-I)

STABILISER-I
Start date: March 25, 2015
Phase: N/A
Study type: Interventional

In the search for a novel marker of stroke that could be rapidly assessed in blood, the investigators developed a point-of-care (POC) lateral flow device (LFD) that rapidly (< 15 min) detects levels of a biomarker that is released into blood following neuronal injury associated with stroke and traumatic brain injury. The protein's expression in human brain should serve as a useful biomarker of neuronal injury in stroke and traumatic brain injury.

NCT ID: NCT02512029 Withdrawn - Clinical trials for Traumatic Brain Injury

18F-AV-1451 PET Imaging in TBI

Start date: October 2015
Phase: Phase 1
Study type: Interventional

This study will evaluate imaging characteristics of 18F-AV-1451 in subjects with subacute traumatic brain injury.

NCT ID: NCT02510573 Completed - Brain Injuries Clinical Trials

Low Serum Ficolin-3 Levels on Admission Are Associated With Poor Outcomes After Severe Traumatic Brain Injury

Start date: April 2011
Phase: N/A
Study type: Observational

The current study was designed to investigate the change of serum ficolin-3 levels and assess the prognostic predictive effect of serum ficolin-3 levels in the patients with severe traumatic brain injury.